Collegium Pharmaceutical Inc (COLL)
38.79
-2.11
(-5.16%)
USD |
NASDAQ |
Mar 28, 16:00
38.79
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical Price to Book Value: 6.344 for March 28, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 27, 2024 | 6.689 |
March 26, 2024 | 6.53 |
March 25, 2024 | 6.568 |
March 22, 2024 | 6.496 |
March 21, 2024 | 6.486 |
March 20, 2024 | 6.344 |
March 19, 2024 | 6.208 |
March 18, 2024 | 6.435 |
March 15, 2024 | 6.393 |
March 14, 2024 | 6.219 |
March 13, 2024 | 6.263 |
March 12, 2024 | 6.116 |
March 11, 2024 | 6.133 |
March 08, 2024 | 6.149 |
March 07, 2024 | 6.084 |
March 06, 2024 | 5.998 |
March 05, 2024 | 5.938 |
March 04, 2024 | 6.056 |
March 01, 2024 | 6.072 |
February 29, 2024 | 6.003 |
February 28, 2024 | 5.980 |
February 27, 2024 | 6.016 |
February 26, 2024 | 5.979 |
February 23, 2024 | 5.944 |
February 22, 2024 | 5.366 |
Date | Value |
---|---|
February 21, 2024 | 5.194 |
February 20, 2024 | 5.246 |
February 16, 2024 | 5.328 |
February 15, 2024 | 5.552 |
February 14, 2024 | 5.377 |
February 13, 2024 | 5.264 |
February 12, 2024 | 5.511 |
February 09, 2024 | 5.475 |
February 08, 2024 | 5.452 |
February 07, 2024 | 5.431 |
February 06, 2024 | 5.436 |
February 05, 2024 | 5.411 |
February 02, 2024 | 5.370 |
February 01, 2024 | 5.474 |
January 31, 2024 | 5.390 |
January 30, 2024 | 5.455 |
January 29, 2024 | 5.526 |
January 26, 2024 | 5.411 |
January 25, 2024 | 5.461 |
January 24, 2024 | 5.404 |
January 23, 2024 | 5.375 |
January 22, 2024 | 5.464 |
January 19, 2024 | 5.380 |
January 18, 2024 | 5.36 |
January 17, 2024 | 5.339 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.409
Minimum
Dec 01 2021
9.912
Maximum
Feb 07 2020
4.375
Average
4.219
Median
Jun 27 2023
Price to Book Value Benchmarks
Cytokinetics Inc | -- |
Immunogen Inc (DELISTED) | -- |
Puma Biotechnology Inc | 4.790 |
AnaptysBio Inc | 6.853 |
Crinetics Pharmaceuticals Inc | 6.759 |
Price to Book Value Related Metrics
PE Ratio | 32.60 |
PS Ratio | 3.096 |
Price to Free Cash Flow | 6.397 |
Price | 38.79 |
Earnings Yield | 3.07% |
Market Cap | 1.240B |
Operating PE Ratio | 10.51 |
Normalized PE Ratio | 20.74 |